Despite some falloff in consumer interest, anti-obesity drugs are still likely to have profound implications at both the macro and sectoral level.

Ed Stanley: Weight Loss Drugs and the Global Economy

Short, thoughtful and regular takes on recent events in the markets from a variety of perspectives and voices within Morgan Stanley.

Business

Investing

Careers

Management & Marketing

Business News

Shopping

In a generally positive environment for corporate credit, the recent performance of high-yield bonds in the telecom, media and technology (TMT) sector offers a market contrast. Our Lead Analyst for High-Yield TMT joins our Head of Corporate Credit Research to explain the divergence.

Why TMT Bonds Are Underperforming

Our Chief Europe Economist explains why the region’s outlook over the next year is trending upward, including how higher growth will lead to lower interest rates this cycle.

European Economic Outlook: Decidedly More Optimistic

Our Global Head of Fixed Income and Thematic Research reflects on Japanese investors’ interest in the outcome of the upcoming presidential vote in the US.

Global Questions About the US Elections

Our Chief Europe Equity Strategist explains why she is forecasting a 23 percent total return for European equities over the next year.

Midyear European Equities Outlook: In the Sweet Spot

Our Head of Corporate Credit Research explains why moderate economic growth offers opportunities in credit markets – if investors choose carefully.

Ed Stanley: Weight Loss Drugs and the Global Economy

Download our free app to listen on your phone